Short Form Prospectus
Verisante Technology, Inc. Files Preliminary Short Form Base Shelf Prospectus
September 20, 2013 at 7:23 pm
VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has filed a preliminary short form base shelf prospectus ("Prospectus") with the securities regulatory authorities in the provinces British Columbia, Ontario and Alberta.
Under the Prospectus, Verisante may offer and issue from time to time any combination of common shares, warrants to purchase common shares and units (collectively, the "Securities") up to an aggregate offering of $10,000,000 during the 25-month period that the Prospectus, including any amendments thereto, remains effective. Securities may be offered separately or together, in amounts, at prices and on terms to be determined based on market conditions at the time of sale and set forth in an accompanying prospectus supplement (a "Prospectus Supplement").
The Company has engaged Jordan Capital Markets, Inc. as agent for an initial offering of up to $2.5 million. Verisante will file the details of the engagement and offering in a Prospectus Supplement after the Company files the final short form base shelf Prospectus.
The net proceeds to Verisante from the sale of Securities and the proposed use of those proceeds will be set forth in the applicable Prospectus Supplement. The principal business objective to be achieved with the proceeds is to further develop and the Company’s product offerings, including Aura™, a device for the detection of all major forms of skin cancer, finance manufacturing of Aura™ devices, to pursue regulatory approval in the United States for Aura™, for ongoing additional product development of other technologies, including multispectral imaging, rapid Raman systems for endoscopic applications, and fluorescence and reflectance imaging systems, and to cover general and administrative costs and other general corporate purposes for the next 12 months.
The Company also announced today that it has retained Kilmer Lucas Inc. (“Kilmer”) to help increase investor awareness throughout North America.
The agreement with Kilmer is for a period of 12 months. Under the terms of the agreement, the Company will pay a consulting fee to Kilmer of $6,500 per month plus approved expenses incurred on behalf of the Company
Read more at http://www.stockhouse.com/companies/bullboard/v.vrs/verisante-technology,-inc?postid=21739515#uw2Te698ekw3xxmW.99 |
